Bow Capital — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Finally offers an AI-powered accounting and finance software suite that automates bookkeeping and financial tasks.
AI & Machine LearningEnterprise SoftwareFintechSaaSTokyo, US
Edwin Mejia(Founder)inFelix Rodriguez(Founder)inGlennys Rodriguez(Founder)in
Co-investors500 GlobalClear Haven Capital ManagementPlug and Play VenturesActive CapitalAmicus Capital PartnersB Capital Group+8 more
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechMedical DevicesWellness & FitnessSacramento, US
David J. Kyle(Executive Officer, Director)inJ. Bruce German(Co-founder)David Mills(Founder)inCarlito Lebrilla(Founder)Daniela Barile(Founder)Samara Freeman(Founder & Executive Director, Regulatory Affairs & Intellectual Property)in
Co-investorsAcre Venture PartnersHorizons VenturesiSelect FundLongitude CapitalSpruce Capital PartnersXeraya Capital+1 more
A consulting firm that works with organizations to build high-performing teams, redesign organizational structure, and accelerate product innovation.
Enterprise SoftwareFuture of Work
Co-investorsEdmonton UnlimitedMetrodora Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







.jpeg)











